[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Wang et al., 2020 - Google Patents

A dynamic charge-charge interaction modulates PP2A: B56 substrate recruitment

Wang et al., 2020

View HTML
Document ID
3390366095002946018
Author
Wang X
Garvanska D
Nasa I
Ueki Y
Zhang G
Kettenbach A
Peti W
Nilsson J
Page R
Publication year
Publication venue
Elife

External Links

Snippet

The recruitment of substrates by the ser/thr protein phosphatase 2A (PP2A) is poorly understood, limiting our understanding of PP2A-regulated signaling. Recently, the first PP2A: B56 consensus binding motif, LxxIxE, was identified. However, most validated LxxIxE …
Continue reading at elifesciences.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Similar Documents

Publication Publication Date Title
Wang et al. A dynamic charge-charge interaction modulates PP2A: B56 substrate recruitment
Adhikari et al. PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
Gordon et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
Rana et al. Fatty acyl recognition and transfer by an integral membrane S-acyltransferase
Ishiyama et al. Structure of the Dnmt1 reader module complexed with a unique two-mono-ubiquitin mark on histone H3 reveals the basis for DNA methylation maintenance
Rasool et al. Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex
Kuchay et al. GGTase3 is a newly identified geranylgeranyltransferase targeting a ubiquitin ligase
Chan et al. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
Garvie et al. Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase
James et al. Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain
Obri et al. ANP32E is a histone chaperone that removes H2A. Z from chromatin
Pfoh et al. Crystal structure of USP7 ubiquitin-like domains with an ICP0 peptide reveals a novel mechanism used by viral and cellular proteins to target USP7
Kumar et al. The Ki-67 and RepoMan mitotic phosphatases assemble via an identical, yet novel mechanism
Park et al. Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis
Long et al. Distinct mechanisms govern the phosphorylation of different SR protein splicing factors
Varshney et al. Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM
Estève et al. A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability
Stanevich et al. The structural basis for tight control of PP2A methylation and function by LCMT-1
Zhu et al. Small Ubiquitin-related Modifier (SUMO) Binding Determines Substrate Recognition and Paralog-selective SUMO Modification∗
Schulze-Gahmen et al. The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat
McConnell et al. Identification of a PP2A-interacting protein that functions as a negative regulator of phosphatase activity in the ATM/ATR signaling pathway
Chang et al. Structural basis of SETD6-mediated regulation of the NF-kB network via methyl-lysine signaling
Williams et al. Structural insights into E1 recognition and the ubiquitin-conjugating activity of the E2 enzyme Cdc34
Ruan et al. Nucleosome contact triggers conformational changes of Rpd3S driving high-affinity H3K36me nucleosome engagement
Talapatra et al. The C-terminal region of the motor protein MCAK controls its structure and activity through a conformational switch